This press release may contain "forward-looking statements," as defined in the Private Securities Litigation Reform Act of 1995, as amended. Any such statements are made pursuant to the safe-harbor ...

WEST PALM BEACH, FL--(Marketwired - Sep 24, 2015) - Medytox Solutions, Inc. (MMMS) ("Medytox") today announced that the registration statement on Form S-4 filed by CollabRx, Inc. (CLRX) ("CollabRx"), ...

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) today announced that the global biopharmaceutical company Medytox has selected IQVIA’s Enterprise Quality Management ...

Medytox won a final victory in an administrative lawsuit against the Ministry of Food and Drug Safety, which canceled product approval and ordered a stop to manufacturing and selling the botulinum ...

Korean botulinum toxin makers Medytox and Daewoong Pharmaceutical exchanged fire once again on Wednesday, both claiming to have the upper hand in winning the US International Trade Commission suit.

Medytox Global Anatomy Workshop drew over 350 medical professionals from Taiwan, Japan, and Thailand. Medytox joined the ICLAS 2026 industrial session to share the latest clinical insights and trends.

Medytox, Korea’s largest botulinum toxin maker by market share, said Monday that it has submitted a request for suspension of execution on the Drug Ministry’s order to halt manufacturing and sales of ...

Medytox announced on the 11th that its operating profit in the second quarter of this year was 6.3 billion won, a 55.9% decrease compared to the same period last year. During the same period, sales ...

On the 13th, Medytox announced through its earnings disclosure that it achieved sales of 228.6 billion KRW, operating profit of 20 billion KRW, and net profit of 15.8 billion KRW last year ...

The second trial of the civil lawsuit filed by Medytox, claiming that Daewoong Pharmaceutical "stole the botulinum toxin strain," will officially begin next month. Botulinum toxin, commonly known as ...

Former acting United States Attorney for the Southern District of New York Joon Kim will lead Medytox's legal battle against Daewoong Pharmaceutical over a botulinum toxin (BTX) strain in the U.S., ...